Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Lysosomal Therapeutics patents

List of Lysosomal Therapeutics patents

List of Techo-Bloc patents

List of Dyadic (company) patents

List of Check Point Software Technologies patents

List of companies in StartupAngel's investment portfolio

Founders educated at East China Normal University

Patents where

Current Assignee

Name

is

Lysosomal Therapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10751341 Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders		Lysosomal Therapeutics	Lysosomal Therapeutics		United States Patent and Trademark Office	10751341	August 25, 2020
	‌ US Patent 10570135 Substituted pyrazolo[1,5-A]pyrimidines and their use in the treatment of medical disorders	Patent 10570135 was granted and assigned to Lysosomal Therapeutics on February, 2020 by the United States Patent and Trademark Office.	Lysosomal Therapeutics	Lysosomal Therapeutics		United States Patent and Trademark Office	10570135	February 25, 2020
	‌ US Patent 9840510 Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders	Patent 9840510 was granted and assigned to Lysosomal Therapeutics on December, 2017 by the United States Patent and Trademark Office.	Lysosomal Therapeutics	Lysosomal Therapeutics		United States Patent and Trademark Office	9840510	December 12, 2017
	‌ US Patent 9920061 Imidazo[1,5-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders	Patent 9920061 was granted and assigned to Lysosomal Therapeutics on March, 2018 by the United States Patent and Trademark Office.	Lysosomal Therapeutics	Lysosomal Therapeutics		United States Patent and Trademark Office	9920061	March 20, 2018
	‌ US Patent 9868742 Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b] pyridazines, related compounds, and their use in the treatment of medical disorders	Patent 9868742 was granted and assigned to Lysosomal Therapeutics on January, 2018 by the United States Patent and Trademark Office.	Lysosomal Therapeutics	Lysosomal Therapeutics		United States Patent and Trademark Office	9868742	January 16, 2018
	‌ US Patent 10786508 Substituted imidazo[1,5-A]-pyrimidines and their use in the treatment of medical disorders		Lysosomal Therapeutics	Lysosomal Therapeutics		United States Patent and Trademark Office	10786508	September 29, 2020
	‌ US Patent 9732089 Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders	Patent 9732089 was granted and assigned to Lysosomal Therapeutics on August, 2017 by the United States Patent and Trademark Office.	Lysosomal Therapeutics	Lysosomal Therapeutics		United States Patent and Trademark Office	9732089	August 15, 2017

7 results

0 selected

7 results

0 selected